Global AMR R&D Hub Annual Board and Stakeholder Meeting
Berlin & online | 8–9 December 2025
Global collaboration is frequently cited as essential to addressing complex challenges such as antimicrobial resistance (AMR). The Global AMR R&D Hub’s Annual Board and Stakeholder Meeting, held on 8–9 December 2025 in Berlin and online, demonstrated why this principle matters in practice.
Over two days, Board members, Observers, and Stakeholders engaged in open and forward-looking discussions on the evolving AMR R&D landscape and the Hub’s strategic direction. The meeting provided a platform for exchange across sectors, regions, and disciplines, generating concrete insights to inform future action.
Key discussion themes included:
-
Updates from Member countries, organisations, Observers, and Stakeholders on national and institutional priorities
-
In-depth discussions on market incentives and One Health research and development
-
Presentations and exchange with new partners, highlighting opportunities for collaboration
-
Emerging consensus on the transformative potential of artificial intelligence to strengthen AMR R&D and decision-making
-
Reflections on the forthcoming establishment of the Independent Panel on Evidence for Action against AMR (IPEA)
-
Review of the impact of the Hub’s 2025 activities and strategic guidance for the next phase of work
A central message throughout the meeting was the continued importance of collaboration and multilateralism. AMR is a global challenge, and in a constrained funding environment, coordinated, evidence-informed action is critical to achieving sustainable progress. The partnerships and discussions fostered during the meeting will shape the Secretariat’s work and support informed decision-making across the Hub’s network.
The Secretariat extends its sincere thanks to all Board members, Observers, Stakeholders, and partners for their engagement, expertise, and continued commitment to collective action on AMR.
Special thanks are also due to the Chair, Eirik Rødseth Bakka, for his leadership and facilitation of the meeting, and to Lisa Heinrich and the Wellcome Trust for generously hosting the meeting.
The Global AMR R&D Hub looks forward to building on this momentum and translating shared priorities into impact in 2026 and beyond.
